ArticleBMC genomics2025
Genomic analysis of multidrug-resistant Salmonellaenterica Serovar Montevideo isolates in China.
Article in BMC genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- ISFrontiers in cellular and infection microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundAs an important foodborne bacterium, non-typhoidal Salmonella (NTS) is estimated to cause approximately 215,000 deaths worldwide each year. Globally, S. Montevideo has been reported to cause several outbreaks, with low frequencies of antimicrobial resistance (AMR). In China, the information on S. Montevideo isolates was limited, especially the genomic data. This study aimed to characterize the phenotypic and genomic features of 26 S. Montevideo isolates collected in China between 2018 and 2024. During this period, 26 S. Montevideo isolates were collected from different sources in five provinces or municipalities in China. Minimum inhibitory concentrations (MICs) of nine antimicrobial agents were determined using the broth microdilution method. Isolates were sequenced on the Illumina platform to identify antimicrobial resistance genes, virulence genes, mobile genetic elements (MGEs), and phylogenetic relationships with global isolates.
resultsThe whole length of the 26 assembled genome sequences ranged from 4,612,761 bp to 5,071,299 bp. There were three sequence types (STs), among which ST-4 (61.5%, 16/26) was predominant, followed by ST-10844 (34.6%, 9/26) and ST-316 (3.8%, 1/26). A total of 21 isolates (80.8%) harbored multidrug resistance (MDR). They showed AMR phenotypes to ampicillin (76.9%, 20/26), cefotaxime (26.9%, 7/26), and ciprofloxacin (69.2%, 18/26; including three ciprofloxacin-intermediate isolates), corresponding to AMR genes and/or chromosomal point mutations of β-lactams (76.9%, 20/26) and fluoroquinolones (100%, 26/26). All ST-10844 isolates possessed MDR, with higher proportions of resistance to cefotaxime and tetracycline. The corresponding AMR genes were mainly carried by two plasmids, IncHI2 and pKPC-CAV1321. The number of virulence genes among the S. Montevideo genomes ranged from 151 to 153, with type III secretion system genes (T3SS; n = 86) predominant. The ranges of the number of prophages, Salmonella Pathogenic Islands (SPIs), plasmid replicons, and MGEs were 2-4, 8-10, 0-5, 17-30, respectively. Phylogenetic analysis showed that global S. Montevideo strains can be divided into five clades, including a novel clade, clade V. Most Chinese isolates (96.6%, 28/29) were assigned to clade II. All the ST-10,844 isolates were from mainland China and assigned to clade II, constituting a distinct cluster.
conclusionThis study is the first report to characterize S. Montevideo genomes from China. The phenotypic and genomic characteristics of Chinese S. Montevideo isolates were distinct from isolates of other countries, standing out with MDR and tending to be waterborne. A ST-10844 cluster was identified, with higher frequencies of resistance to cefotaxime and tetracycline.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.